MD, Scientific advisor, Director of Retina Research at Ophthalmic Consultants of Boston (OCB)
Jeffrey S Heier, MD, is the Co-President and Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston (OCB), one of the largest multi-specialty ophthalmology practices in the United States. Dr Heier received his medical degree from Boston University, completed an internship and residency at Fitzsimons Army Medical Center, and vitreoretinal fellowship at Ophthalmic Consultants of Boston/Tufts School of Medicine. Dr Heier served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star. He is on the Executive Board of the Retina Society and the Executive Committee of the American Society of Retina Specialists. He is one of the leading retinal clinical researchers for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. Dr Heier is a scientific advisor to many companies, lectures nationally and internationally, and has authored numerous peer-reviewed works. Dr. Heier is a scientific adviser to Stealth BioTherapeutics Inc.
Visit website: https://www.eyeboston.com/doctor/jeffrey-heier-md/
See also: Stealth BioTherapeutics - Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Jeffrey Heier News
Elamipretide: a drug to protect your eyes from AMD
Ophthalmology Times - 07-Jul-2021
Elamipritide protects your retinal cells from undergoing degenerationRead more...